September 15, 2017
When NASCAR drivers hit the Chicagoland Speedway, Enumclaw's Kasey Kahne will have a little extra luck on his side. Wyatt Zender, an outgoing, outdoorsy 9-year old, was diagnosed with Hodgkin lymphoma at Seattle Children’s.
September 6, 2017
The FDA approved a new drug therapy for pediatric leukemia that uses immunotherapy, or the re-engineering of a person’s own T cells to enable them to fight cancer.
August 11, 2017
Seattle Children's Ben Towne Center for Childhood Cancer Research is actively fighting pediatric leukemia by harvesting and reprogramming a child's own T cells and using the immune system to fight cancer.
July 27, 2017
With 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving complete initial remission in their PLAT-02 trial, researchers at Seattle Children’s are continuing to improve the experimental immunotherapy and reduce the rate of relapse.